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This month we discuss three types of rare genomic varia-
tion and specifically how rare variants impact on cognition
and behaviour. Each of the highlighted studies employs a
different outcome measure: diagnosis of autism spectrum
disorder or intellectual difficulties; performance on cogni-
tive testing; and the number of years in education. All
harness the extreme power of massively parallel sequenc-
ing or genomic arrays together with innovative bioinfor-
matic analyses. The first study identifies ‘ultra-rare
variation’, these are variants that are never, or almost
never, seen in the unaffected population. The second
identifies larger areas of rearranged genomic DNA which
change the gene dosage for one or many genes, termed
copy number variants. These variants may cluster in pre-
viously recognised sites or they may exist idiosyncratically.
The third study uses a strategy to focus on variation at the
loci that vary most between us and other species and are,
therefore, thought to be of special significance for identi-
fying what defines the human species; communication and
civilised behaviour. Genomic areas that are highly diver-
gent are known as human-accelerated regions (HARs) and
damaging mutations in these areas may be more likely to
cause a cognitive or behavioural phenotype.
Ultra-rare disruptive and damaging mutations
influence educational attainment in the general
population
Ganna and colleagues set out to identify ultra-rare genetic
variants and explore whether the presence of these variants
in highly constrained genes was associated with poorer
educational performance. They had access to 14,133 indi-
viduals from Sweden, Estonia, and Finland; 5047 of whom
had schizophrenia. They initially identified demographic
associations with the number of years of education; lower
in Finnish populations, lower in men, and lower in older
people. They identified the ultra-rare variants from either
exome or the genic component of genome sequencing and
focussed only on highly conserved genes identifying dis-
rupting mutations in 25%; damaging variants in 24%; and
synonymous variants not predicted to change the protein in
78%.
Each disruptive or damaging mutation reduced the mean
number of years of education by 3 months. Each subse-
quent disruptive or damaging mutation reduced the chances
of attending college by 14%. These associations remained
when 34% of the cohort with schizophrenia were analysed
separately. The impact on years of education was more
than doubled when highly conserved genes enriched for
brain expression were the sole focus. They then set about
confirming prior genomic associations with educational
attainment. The presence of a pathogenic copy number
variant reduced the time in education by 7.6 months. This
was a large effect but not seen frequently (1.34% of the
sample). In contrast, modelling the polygenic risk score
could explain 2.9% of the variability in educational
attainment, compared to 0.4% for the ultra-rare variants.
This study joins a nascent body of evidence highlighting
the importance of ultra-rare variation in the genetic
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architecture of common diseases alongside common vari-
ants and pathogenic copy number variants.
Ganna A. et al. (2016) Nat Neurosci. (Epub ahead of print)
doi:10.1038/nn.4404.
Cognitive performance among carriers
of pathogenic copy number variants: analysis
of 152,000 UK Biobank subjects
The UK Biobank is a cohort collection of half a million
older adult volunteers, both with and without disease. In
addition to donating DNA for analysis, they undergo a
number of physical and cognitive tests. Analysis of the first
available data set of 152,728 adults enabled Kendall and
colleagues to produce a map of copy number variants.
Limiting themselves to a set of 93 copy number variants
that are strongly associated with disease, they confirmed
that population frequencies were similar to that seen in
smaller control samples elsewhere. The most common
copy number variant, 15q11.2, was found in 0.5% of the
cohort.
They then examined the results of cognitive function
testing of participants, comparing the unaffected majority
with 1087 individuals who had one of the 12 copy number
variants associated with schizophrenia, and 484 who had
one of the 41 associated with other neurodevelopmental
disorders. Copy number variant carriers performed less
well on all 14 tests, with 9 of these surviving statistical
corrections for multiple testing. Both groups with copy
number variants were less likely to go to college or
University or achieve examinations aged 18 (A levels).
Those with copy number variants were also more likely to
have jobs that require less training or fewer academic
qualifications. This study confirms prior associations that
even in those ‘healthy’ individuals with a pathogenic copy
number variant, cognitive performance is impaired. These
data are of importance for genetic counsellors who have the
unenviable task of advising families on these rare genomic
mutations with pleotropic effects.
Kendall K. et al. (2016) Biol Psychiatry (Epub ahead of
print) doi:10.1016/j.biopsych.2016.08.014
Mutations in human-accelerated regions disrupt
cognition and social behaviour
Most HARs are within close proximity of a gene (within
1 Mb) and it is proposed that they act as transcriptional
enhancers. Until now, only circumstantial evidence linked
mutations in HARs to neurological disorders. In this study,
investigators first identified 2737 HARs in six published
papers. The HARs were twice as likely to not carry rare
variants, suggesting that they are both critical and con-
served. Prediction tools were then used to look at gene
expression within HAR regions. HARs show significant
enrichment for foetal and adult brain profiles (p\ 0.0001),
suggesting a preference for brain activity. Over 80% of
HARs overlapped areas of active transcription, promoters,
or enhancers. This included 45% in neural samples of
which many were tissue specific, including 168 HARs
specific for neural tissue. HARs were also enriched for
transcription binding sites, 78%, p\ 0.0001.
Investigators then proceeded to link their data and map 576
HARs to promoter regions in over 700 genes. Of the 132 target
genes associated with an OMIM disorder, 28 (p = 0.008)
included autism spectrum disorder or intellectual disability in
man. Not only were HARs interacting with flanking gene
promoters, but also the flanking and target genes were found to
be particularly sensitive to gene dosage. This suggests that
HARsmight provide a new cause of dose regulation for highly
constrained and haplosensitive genes: the type of genes known
to cause autism spectrum disorder, intellectual difficulties, and
epileptic encephalopathy. HAR genes were also enriched for
neural development, neuronal differentiation, and axonogene-
sis. More strikingly, they were also enriched for disorders of
brain morphology, for autism spectrum disorder, schizophre-
nia, and, curiously, autonomic function dysfunction.
Analysis of 2100 sibling-matched autism spectrum dis-
order probands also identified a 6.5-fold increase in de
novo copy number variants containing HARs. The authors
report that this pattern was only seen in de novo but not
inherited copy number variants and estimated that HAR-
containing copy number variants may account for up to
1.8% of all autism cases. This multi-method study then
built the scientific case for (1) a mutation in HAR 426
affecting the gene CUX1; (2) a HAR mutation between
DPYD and PTBP2 affecting PTBP2; and (3) two separate
homozygous HAR mutations near GPC4. Finally, by ana-
lysing the genomes of consanguineous individuals with
autism and looking for damaging mutations inherited from
both parents but affecting the same locus (biallelic), they
estimated that this may be the causative mechanism in 5%
with a similar familial structure. Furthermore, with so
many mutations interacting with SOX2, they also make a
compelling argument for the role of HARs in neurogenesis.
Doan RN. et al. (2016) Cell 167(2):341–354.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
J Neurol
123
